Combination of radiation therapy-immunotherapy for head and neck cancers: Promises kept?

被引：2
|
作者：
Huguet, F. [1 ]
Durand, B. [1 ]
Atallah, S. [2 ]
Prebet, C. [3 ]
Richard, S. [3 ]
Baujat, B. [2 ]
机构：
[1] Hop Tenon, Serv Oncol Radiotherapie, 4 Rue Chine, F-75020 Paris, France
[2] Serv Oto Rhino Laryngol Chirurg Cerv Faciale, Paris, France
[3] Sorbonne Univ, Serv Oncol Med, Hop Tenon, AP HP, Paris, France
来源：
CANCER RADIOTHERAPIE | 2021年 / 25卷 / 08期
关键词：
Head and neck cancer; Squamous cell carcinoma; Radiotherapy; Chemoradiotherapy; Cisplatin; Immunotherapy; Immune checkpoint inhibitors; PDL1; PD1; Abscopal effect; SQUAMOUS-CELL CARCINOMA; RADIOTHERAPY; CHEMOTHERAPY; NIVOLUMAB; CETUXIMAB; CHEMORADIOTHERAPY; RECURRENT; IMMUNITY; SAFETY; PHASE;
D O I：
10.1016/j.canrad.2021.08.018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Chemoradiotherapy with concurrent cisplatin has been the standard treatment for locally advanced headand neck squamous cell carcinoma (HNSCC) for over 20 years. Recently, immunotherapy, a new therapeutic class, has emerged for patients with recurrent or metastatic HNSCC and has significantly extendedtheir survival. Will it bring the same benefit to patients with localized tumors? There is a strong rationale for combining radiation therapy and checkpoint inhibitors for HNSCC. Indeed, radiation therapy canhave both immunostimulatory and immunomodulatory effects. This is what explains the famous abscopal effect. The aim of this review is to present the data available on the combination of radiation therapyand immunotherapy for HNSCC. (c) 2021 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. Allrights reserved.
引用
收藏
页码：811 / 815
页数：5
相关论文
共 50 条
  • [21] Serial FDG-PET on patients with head and neck cancer: Implications for radiation therapy
    Hentschel, Maria
    Appold, Steffen
    Schreiber, Andreas
    Abramyuk, Andrij
    Abolmaali, Nasreddin
    Kotzerke, Joerg
    Baumann, Michael
    Zoephel, Klaus
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2009, 85 (09) : 796 - 804
  • [22] Recent Research on Combination of Radiotherapy with Targeted Therapy or Immunotherapy in Head and Neck Squamous Cell Carcinoma: A Review for Radiation Oncologists
    Xing, Daniel Tao
    Khor, Richard
    Gan, Hui
    Wada, Morikatsu
    Ermongkonchai, Tai
    Ng, Sweet Ping
    CANCERS, 2021, 13 (22)
  • [23] Combining immunotherapy and radiotherapy in head and neck squamous cell cancers: which perspectives?
    Biau, Julian
    Bourhis, Jean
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (03) : 196 - 202
  • [24] Radiation therapy quality assurance in head and neck radiotherapy - Moving forward
    McDowell, Lachlan
    Corry, June
    ORAL ONCOLOGY, 2019, 88 : 180 - 185
  • [25] Intensity-modulated radiation therapy (IMRT): Toward a new standard for radiation therapy of head and neck cancer?
    Daly-Schveitzer, N.
    Julieron, M.
    Tao, Y. Gan
    Moussier, A.
    Bourhis, J.
    EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2011, 128 (05) : 241 - 247
  • [26] Combinations of immunotherapy and radiation therapy in head and neck squamous cell carcinoma: a narrative review
    Hayman, Thomas J.
    Bhatia, Aarti K.
    Jethwa, Krishan R.
    Young, Melissa R.
    Park, Henry S.
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (05) : 2571 - 2585
  • [27] MR-guided stereotactic radiation therapy for head and neck cancers
    Wang, He
    Yang, Jinzhong
    Lee, Anna
    Phan, Jack
    Lim, Tze Yee
    Fuller, Clifton D.
    Han, Eun Young
    Rhee, Dong Joo
    Salzillo, Travis
    Zhao, Yao
    Chopra, Nitish
    Pham, Mary
    Castillo, Pam
    Sobremonte, Angela
    Moreno, Amy C.
    Reddy, Jay P.
    Rosenthal, David
    Garden, Adam S.
    Wang, Xin
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 46
  • [28] Rebuttal to comment on "Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer"
    Han, James E.
    Zakeri, Kaveh
    Michel, Loren
    Sherman, Eric J.
    Lee, Nancy Y.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (01): : 230 - 231
  • [29] Phase I Study of Capecitabine, Carboplatin and Intensity-modulated Radiation Therapy for Head and Neck Cancer
    Thomas, Christopher Y.
    Read, Paul
    Petroni, Gina
    Reibel, James
    Levine, Paul A.
    ANTICANCER RESEARCH, 2009, 29 (07) : 2869 - 2876
  • [30] A phase II study of docetaxel and carboplatin with concurrent radiation therapy for locally advanced head and neck cancer
    Chitapanarux, Imjai
    Lorvidhaya, Vicharn
    Tharavichitkul, Ekasit
    Mayurasakorn, Somvilai
    Sittitrai, Pichit
    Pattarasakulchai, Tienchai
    Tananuwat, Rak
    Srivanitchapoom, Chonticha
    AURIS NASUS LARYNX, 2011, 38 (01) : 108 - 113
12345